Keith L. Dixon

Array ( [id] => 8516935 [patent_doc_number] => 20120316342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'THERAPEUTIC AGENT FOR HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 13/576269 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 27349 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153840 [patent_doc_number] => 08586746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Amino-aza-adamantane derivatives and methods of use' [patent_app_type] => utility [patent_app_number] => 13/012130 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31164 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13012130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663725 [patent_doc_number] => 20110312994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'BIPHENYL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/011100 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63225 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312994.pdf [firstpage_image] =>[orig_patent_app_number] => 13011100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227647 [patent_doc_number] => 08633316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Producing method of nitrogen containing condensed heterocyclic compound' [patent_app_type] => utility [patent_app_number] => 13/009989 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3169 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13009989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055746 [patent_doc_number] => 20110112106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE' [patent_app_type] => utility [patent_app_number] => 12/987004 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 91976 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112106.pdf [firstpage_image] =>[orig_patent_app_number] => 12987004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046885 [patent_doc_number] => 08541438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines' [patent_app_type] => utility [patent_app_number] => 12/974459 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91320 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12974459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257859 [patent_doc_number] => 08207338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Phosphonic acid compounds as inhibitors of serine proteases' [patent_app_type] => utility [patent_app_number] => 12/973013 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22317 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12973013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527860 [patent_doc_number] => 08304430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Phosphonic acid compounds as inhibitors of serine proteases' [patent_app_type] => utility [patent_app_number] => 12/972744 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22324 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12972744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039408 [patent_doc_number] => 20110092457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'NOVEL PHOSPHONIC ACID COMPOUNDS AS INHIBITORS OF SERINE PROTEASES' [patent_app_type] => utility [patent_app_number] => 12/972891 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22315 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092457.pdf [firstpage_image] =>[orig_patent_app_number] => 12972891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858660 [patent_doc_number] => 08461195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Phosphonic acid compounds as inhibitors of serine proteases' [patent_app_type] => utility [patent_app_number] => 12/972848 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22285 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12972848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989852 [patent_doc_number] => 09035057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-19 [patent_title] => 'Dihydroethidine analogues and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/516783 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 5435 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959551 [patent_doc_number] => 20110183938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => '1,7-DIAZACARBAZOLES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/967864 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 85861 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183938.pdf [firstpage_image] =>[orig_patent_app_number] => 12967864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662553 [patent_doc_number] => 08809532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Aza-ring fused indole and indoline derivatives' [patent_app_type] => utility [patent_app_number] => 12/968107 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22422 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12968107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8921163 [patent_doc_number] => 08487100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof' [patent_app_type] => utility [patent_app_number] => 12/967871 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 18359 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12967871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987783 [patent_doc_number] => 20110098468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'NK1 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/967132 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32096 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098468.pdf [firstpage_image] =>[orig_patent_app_number] => 12967132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9778029 [patent_doc_number] => 08853235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Polymorphs and salts of a kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 12/952879 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 86 [patent_figures_cnt] => 86 [patent_no_of_words] => 36446 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12952879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032548 [patent_doc_number] => 09073854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Aromatic sulfonium salt compound' [patent_app_type] => utility [patent_app_number] => 13/389821 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12774 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7809736 [patent_doc_number] => RE043244 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2012-03-13 [patent_title] => 'Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use' [patent_app_type] => reissue [patent_app_number] => 12/945057 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8389 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/043/RE043244.pdf [firstpage_image] =>[orig_patent_app_number] => 12945057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359627 [patent_doc_number] => 20120214784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/504176 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26106 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317513 [patent_doc_number] => 08232289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Spiropiperidine compounds as ORL-1 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/943187 [patent_app_country] => US [patent_app_date] => 2010-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29342 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12943187 [rel_patent_id] =>[rel_patent_doc_number] =>)